Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
Bank of America Corp DE Sells 40,615 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
09:50am, Wednesday, 22'nd Apr 2020
Bank of America Corp DE reduced its position in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 51.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:19pm, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 20) * Abbott Laboratories (NYSE: ABT) * Acceleron Phar
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:00am, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 20)
Abbott Laboratories (NYSE...
Frontier Capital Management Co. LLC Sells 138,229 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
10:14am, Monday, 20'th Apr 2020
Frontier Capital Management Co. LLC cut its position in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 91.5% during the first quarter, according to the company in its most recent disclosure with the Secu
Ascendis Pharma (ASND) Received its Third Buy in a Row
10:11am, Monday, 20'th Apr 2020
After Merrill Lynch and Oppenheimer gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another Buy, this time from
Ascendis Pharma (ASND) Received its Third Buy in a Row
10:11am, Monday, 20'th Apr 2020
After Merrill Lynch and Oppenheimer gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another Buy,
ChemoCentryx Inc (NASDAQ:CCXI) Short Interest Up 15.6% in March
10:56am, Friday, 17'th Apr 2020
ChemoCentryx Inc (NASDAQ:CCXI) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 2,570,000 shares, a growth of 15.
Zacks Investment Research Upgrades ChemoCentryx (NASDAQ:CCXI) to "Buy"
09:42am, Thursday, 16'th Apr 2020
ChemoCentryx (NASDAQ:CCXI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday, Zacks.com reports. The firm currently has a $52.00 ta
Geode Capital Management LLC Has $22.68 Million Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
11:04am, Wednesday, 15'th Apr 2020
Geode Capital Management LLC raised its holdings in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 11.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission.
AQR Capital Management LLC Acquires Shares of 5,612 ChemoCentryx Inc (NASDAQ:CCXI)
09:22am, Monday, 13'th Apr 2020
AQR Capital Management LLC acquired a new stake in ChemoCentryx Inc (NASDAQ:CCXI) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
ChemoCentryx (NASDAQ:CCXI) Downgraded by Zacks Investment Research
11:22am, Sunday, 12'th Apr 2020
Zacks Investment Research lowered shares of ChemoCentryx (NASDAQ:CCXI) from a buy rating to a hold rating in a research report released on Wednesday morning, Zacks.com reports. According to Zacks, “
ChemoCentryx Inc (NASDAQ:CCXI) Receives Consensus Rating of "Buy" from Brokerages
10:36am, Sunday, 12'th Apr 2020
ChemoCentryx Inc (NASDAQ:CCXI) has received an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the
Alliancebernstein L.P. Increases Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
09:53am, Sunday, 12'th Apr 2020
Alliancebernstein L.P. increased its stake in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 48.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 88,150 shares of the biopharmaceutic
Stock Market's Next Move
07:00pm, Thursday, 09'th Apr 2020
The market remains unsettled but is moving higher as it expects good things to happen after the hot spots peak. The impact of the pandemic will keep expanding d
Cubist Systematic Strategies LLC Sells 8,499 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
09:20am, Wednesday, 08'th Apr 2020
Cubist Systematic Strategies LLC reduced its position in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 31.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commis
